Nature's Sunshine Products, Inc. announced on June 30, 2025, that it has agreed to purchase Fosun Pharma's interests in two joint ventures for a total of $7 million, after Fosun sold enough shares to drop below 5% ownership. This acquisition is part of their ongoing efforts to expand business operations in China.